Cytokinetics Inc. buy Barclays PLC
Start price
23.05.24
/
50%
€46.40
Target price
23.05.25
€87.72
Performance (%)
6.03%
Price
13.06.24
€49.20
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC shows slight gains of 6.03%. This prediction currently runs until 23.05.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Cytokinetics Inc. | 0.408% |
iShares Core DAX® | -2.926% |
iShares Nasdaq 100 | 4.462% |
iShares Nikkei 225® | 0.306% |
iShares S&P 500 | 2.488% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Barclays PLC from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat